Risk Score to Assess Cardiovascular Complications in Stem Cell Transplant Recipients
Conexiant
May 1, 2024
A novel points-based risk score predicts cardiovascular complications post-hematopoietic stem cell transplantation.
The risk score utilizes data from the Cardiovascular Registry in Bone Marrow Transplantation (CARE-BMT).
Among 3,300 patients, 4.1% and 13.9% experienced cardiovascular events within 100 days and 5 years, respectively.
Allogeneic transplant recipients had a higher rate of long-term cardiovascular events compared to autologous recipients.
The risk score was effective for both allogeneic and autologous transplant recipients, as well as a separate cohort of over 900 patients.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
News Staff
Affiliations:
Specialties:
Areas of Expertise: